<DOC>
	<DOC>NCT00734578</DOC>
	<brief_summary>The purpose of this study is to assess the efficacy and safety of SPD503 in subjects with ADHD when co-administered with psychostimulants in children and adolescents aged 6-17 years with a diagnosis of ADHD with a sub-optimal, partial response to stimulants.</brief_summary>
	<brief_title>Efficacy and Safety of SPD503 in Combination With Psychostimulants</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Guanfacine</mesh_term>
	<criteria>Healthy subjects with ADHD currently taking a stable dose of psychostimulant for at least 4 weeks Aged 617 years with a suboptimal Partial response to stimulants Subjects must be &lt; 95th percentile for BMI with weight &gt;= 55lbs and &lt;= 176lbs</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>